Navigation Links
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Date:10/1/2008

termezzo(R) 3.5 mg or placebo at home, at the time they awakened in the middle of the night and had difficulty returning to sleep. This Phase 3 clinical trial also met its primary endpoint of significantly reducing the time required for the patient to return to sleep versus placebo. After dosing and returning to sleep, patients in the outpatient study who were randomized to Intermezzo(R) also reported fewer subsequent awakenings and less time awake during the remainder of the night. There was no evidence of next day residual sedative effects after middle of the night use of Intermezzo(R) versus placebo.

Glenn A. Oclassen, President and Chief Executive Officer of Transcept, commented, "The submission of the Intermezzo(R) NDA achieves a key milestone for the Transcept team and advances our efforts to gain FDA approval for Intermezzo(R) as the first sleep aid developed specifically to be used in the middle of the night when patients awaken and have difficulty returning to sleep. This NDA submission is the latest in a series of transformative events for Transcept, which have recently included our execution of a definitive merger agreement with Novacea, Inc. Assuming that this proposed merger closes near the end of 2008, Transcept is expected to begin 2009 with an estimated cash balance of $88 to $92 million, which we believe will enable us to carry out our plan to successfully commercialize Intermezzo(R)."

Middle of the Night Awakenings & Intermezzo(R)

According to a recent independent study, conducted by Dr. Maurice Ohayon of the Stanford Sleep Epidemiology Research Center, middle of the night awakening is the most frequently reported insomnia symptom. This study estimates that 35% of American adults experience a middle of the night awakening at least three times per week (Journal of Psychiatric Research, in press).

All of the most commonly prescribed sleep aids are designed to produce approximately seven to eight hours of sleep, and can be
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
2. Critical Pharmaceuticals Enter Sustained Release hGH Arena
3. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
4. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
5. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
6. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
7. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
8. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
9. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
10. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
11. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  Strategic Health Services, Inc. (SHS), a leading ... a strategic agreement with QualCare, Inc., a leading provider of ... regional marketplace.  This agreement will further QualCare,s population ... solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 member ...
(Date:12/17/2014)... ANGELES , Dec. 17, 2014  ImmunoCellular ... the US Patent and Trademark Office (USPTO) has ... ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting six ... The claims of US Patent No. 8,871,211, which ... neural cancer by administering a dendritic cell composition ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... May 24 Perrigo Company (Nasdaq: PRGO ; TASE) ... will present at the Citi Investment Research Global Health Care Conference on ... the New York Hilton.  The presentation will be webcast on the following ... , , ...
... , MOSCOW , May 24 The international forum "Drug ... held in Moscow on June 9 and 10, 2010, ... , Heads ... gather in Moscow for a conference initiated by the Russian News ...
Cached Medicine Technology:Drug Production in Afghanistan: A Challenge for the International Community 2
(Date:12/17/2014)... Marlborough, Mass. (PRWEB) December 17, 2014 ... College of Osteopathic Medicine (ACOM), which welcomed its ... Virtual Desktop Infrastructure (VDI) to seamlessly support bring ... learning – and teaching – experience. The solution, ... Citrix NetScaler , Dell server and storage ...
(Date:12/17/2014)... HeartMath® Inc., recognized as one of the world’s ... heart coherence and the physiology of emotions, is ... to chipset manufacturers and consumer electronics companies. The ... its HRV solutions, tap into its HRV sensor ... HRV databases and algorithms for developing consumer products. ...
(Date:12/17/2014)... 2014 In its comprehensive analysis of ... Argus Claim Review division have recently identified out-of-network and ... ways savings are achieved on behalf of employer-clients. ... dollars in savings to Argus each year, with a ... explained by Tom Doney, Cypress president and CEO, these ...
(Date:12/17/2014)... IL (PRWEB) December 17, 2014 Now ... Awards celebrate the best of the best in senior ... award is only given to communities and agencies that ... the SeniorAdvisor.com site. Of the nearly 100,000 providers currently ... award. Winners of the SeniorAdvisor.com Best of 2015 Awards ...
(Date:12/17/2014)... Dec. 15, 2014 (HealthDay News) -- As gas prices ... deaths, a new study suggests. In times of ... of those riders are inexperienced, the researchers explained. ... California, which has the highest number of motorcycle registrations ... of motorcyclist deaths. The analysis revealed a strong ...
Breaking Medicine News(10 mins):Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2
... of Michigan researchers have identified the first biomarker of ... a simple blood test that should solve a treatment ... after bone marrow transplants. The biomarker also makes it ... dying of graft-versus-host disease, or GVHD. GVHD is ...
... R. Palmer Beasley, M.D., Ashbel Smith Professor at The ... awarded the Hepatitis B Foundation,s Distinguished Scientist Award 2010. ... provides long-term protection against hepatitis B infection, which is ... the world. Ultimately, HBV can be eradicated," said Beasley. ...
... ... major concerns that could affect efforts to effectively implement electronic health records under ... (CHIME). , ... Ann Arbor, MI (Vocus) -- Reporting, product certification and implementation deadlines represent ...
... ... ... 20 years with very little innovation, the world of cast removal has changed. Sanford ... , , ,With an operating sound level just above a whisper, and no vibration, the ...
... Minn., Jan. 8 Grubb & Ellis Healthcare REIT II, ... to acquire the Center for Neurosurgery and Spine, a 36,600-square-foot, ... Sartell. The acquisition is subject to customary closing conditions and ... , Located at 162 19th St. South, the ...
... and benefit people with asthma, heart and lung disease, ... News) -- The U.S. Environmental Protection Agency on Thursday ... to a variety of health problems, including aggravated asthma ... , The new standards, if adopted by the agency ...
Cached Medicine News:Health News:Blood test could improve graft-versus-host disease treatment 2Health News:Blood test could improve graft-versus-host disease treatment 3Health News:CHIME Voices Concerns About Proposed ARRA Regulations 2Health News:CHIME Voices Concerns About Proposed ARRA Regulations 3Health News:CHIME Voices Concerns About Proposed ARRA Regulations 4Health News:New 'Kid-Friendly' Cast Removal Tool Now at Sanford 2Health News:Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn. 2Health News:Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn. 3Health News:Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn. 4Health News:EPA Unveils Stricter Smog Standards 2Health News:EPA Unveils Stricter Smog Standards 3
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
... Amylase powder reagent once reconstituted offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... powder reagent provides a long shelf ...
LCD chart display...
Mobile offers full life cycle service for Sp02 accessories that are the vital link between pulse oximeter and patient...
Medicine Products: